International Validation of Two Non-motor Scales in PD (NFS and SPARK)
Recruiting
Observational Study
Parkinson's Disease
Non-motor Symptoms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 30 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Written informed consent;
2. PD, according to the MDS criteria;
3. Age of participants \> 30 and \< 75 years;
4. Being fluent in the language in which the scales are applied.
Exclusion Criteria:
1\. Presence of PD dementia (defined as MoCA score \< 24).
Contacts